Showing 3431-3440 of 18626 results for "".
Updates in Glomerular Disease
https://reachmd.com/programs/cme/updates-in-glomerular-disease/14891/Explore cases of IgAN, FSGS, and AAV to further your knowledge of the underlying mechanisms of glomerulonephritis and sclerosis and improve outcomes.Switching Strategies: Switch or Stay—What’s Your Call?
https://reachmd.com/programs/cme/switching-strategies-switch-or-staywhats-your-call/51487/Explore IBD from diagnosis to remission with practical cases, treatment strategies, and a treat-to-target approach for optimal patient outcomes.Rethinking Schizophrenia Treatment Through Muscarinic Modulation
https://reachmd.com/programs/cme/rethinking-schizophrenia-treatment-through-muscarinic-modulation/37103/Learn expert insights on muscarinic antipsychotics in schizophrenia, including mechanisms, safety, and switching considerations.Changing the Mindset in the Management of Endometriosis: Hitting the Pause Button on Surgical Procedures and Expanding the Role of GnRH Antagonists
https://reachmd.com/programs/cme/changing-the-mindset-in-the-management-of-endometriosis-hitting-the-pause-button-on-surgical-procedures-and-expanding-the-role-of-gnrh-antagonists/24333/A paradigm change that will impact your clinical practice is occurring in the diagnosis and medical management of endometriosis. Learn more!Best Practices in Nutrition, Drug Management, and Multi-Organ Support in Patients with AKI
https://reachmd.com/programs/kdigo-conversations-nephrology/best-practices-in-nutrition-drug-management-and-multi-organ-support-in-patients-with-aki/14171/How are the kidneys of critically ill patients affected by their drug regimens? And what are the best practices for managing this?Assessing Approvals: FDA Updates on Dexmedetomidine Hydrochloride
https://reachmd.com/programs/the-drug-report/assessing-approvals-fda-updates-on-dexmedetomidine-hydrochloride/12090/The U.S. Food and Drug Administration approves Aurobindo Pharma’s dexmedetomidine hydrochloride in 0.9% sodium chloride injection.Seborrheic Dermatitis Update: A Review of the Etiology and Treatment of Seborrheic Dermatitis
https://reachmd.com/programs/practical-dermatology/seborrheic-dermatitis-update-a-review-of-the-etiology-and-treatment-of-seborrheic-dermatitis/24003/Seborrheic dermatitis (SD) is an inflammatory skin condition that often involves flaky, erythematous patches on sebum-rich areas of the body such as the face and scalp.1 At least 50 million Americans have a form of seborrheic dermatitis on the scalp, more commonly known as dandruff. SD presents in aNot Just a Headache: Migraine Across Women’s Lifespan
https://reachmd.com/programs/cme/not-just-a-headache-migraine-across-womens-lifespan/36591/Review hormonal, diagnostic, and treatment considerations for migraine across women's life stages, including menstrual and menopausal transitions.Alloimmune Neutropenia of the Fetus and Newborn
https://reachmd.com/programs/cme/alloimmune-neutropenia-of-the-fetus-and-newborn/13910/NAIN is rare and potentially life-threatening. What clues can increase your awareness and help you modify the clinical course of this disease?Applying Evidence to Clinical Practice
https://reachmd.com/programs/cme/applying-evidence-to-clinical-practice/36183/Explore advances in AML that integrate risk stratification, molecular profiling, and menin-targeted therapies to optimize care and improve outcomes.